Skip to main content

ADAR1 Partners, LP

No open-market purchases or sales filed in the past year.

Current role at each company

  • KROSKeros Therapeutics, Inc.10% Owneras of Oct 15, 2025
  • PVLAPalvella Therapeutics, Inc.10% Owneras of Aug 12, 2024

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists ADAR1 Partners, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

KROS Keros Therapeutics, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 15, 2025 (view filing)1:24 PM ETOct 15Same dayADAR1 Partners, LP and 3 others10% OwnerSSale−5.39M$17.75−$95.7M−100.0%0 after3 lots
Apr 11, 2025 (view filing)9:57 PM ETApr 92 daysADAR1 Partners, LP and 3 others10% OwnerPPurchase+934.3K$10.13+$9.46M+27.0%4.39M after5 lots

PVLA Palvella Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2024 (view filing)6:48 PM ETAug 9-123 daysADAR1 Partners, LP and 1 other10% OwnerPPurchase+6.00K$15.39+$92.3K+66.2%15.1K after3 lots